Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals

被引:161
作者
Aburahma, Mona H. [2 ]
Badr-Eldin, Shaimaa M. [1 ,2 ]
机构
[1] King Abdulaziz Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Jeddah 21589, Saudi Arabia
[2] Cairo Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Cairo 11562, Egypt
关键词
Compritol (R) 888 ATO; glyceryl behenate; lipid excipients; pharmaceutical formulations; physicochemical characterization; VITRO CONTROLLED-RELEASE; SUSTAINED-RELEASE; NANOPARTICLES SLN; TOPICAL DELIVERY; MATRIX TABLETS; THERMAL CHARACTERIZATION; LUBRICANT PERFORMANCE; CYCLOSPORINE-A; MICROSPHERES; FORMULATION;
D O I
10.1517/17425247.2014.935335
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Compritol (R) 888 ATO is a lipid excipient that is generally used in cosmetic industry as a surfactant, emulsifying agent and viscosity-inducing agent in emulsions or creams. Based on its chemical composition, Compritol 888 ATO is a blend of different esters of behenic acid with glycerol. Areas covered: Recently, there has been great interest in the multiple roles that Compritol 888 ATO plays in various pharmaceutical delivery systems. Accordingly, this review aimed at summarizing the current and potential applications of Compritol 888 ATO in various drug delivery areas. Expert opinion: Different researches have highlighted the feasibility of using Compritol 888 ATO as a lubricant or coating agent for oral solid dosage formulations. It has also been explored as a matrix-forming agent for controlling drug release. At present, the most common pharmaceutical application of Compritol 888 ATO is in lipid-based colloidal drug delivery system such as solid lipid microparticles, solid lipid nanoparticles and nanostructured lipid carriers. Although, Compritol 888 ATO has acceptable regulatory and safety profiles and although the number of articles that emphasize on its applicability as an innovative excipient in pharmaceutical technology is continuously increasing, it is not widely used in the pharmaceutical market products and its use is limited to its sustain release ability in extended release tablets.
引用
收藏
页码:1865 / 1883
页数:19
相关论文
共 100 条
  • [1] Abd El-Halim SM, 2010, DRUG DISCOV THER, V4, P484
  • [2] Sucrose Stearate-Enriched Lipid Matrix Tablets of Etodolac: Modulation of Drug Release, Diffusional Modeling and Structure Elucidation Studies
    Abd-Elbary, Ahmed
    Tadros, Mina Ibrahim
    Alaa-Eldin, Ahmed Adel
    [J]. AAPS PHARMSCITECH, 2013, 14 (02): : 656 - 668
  • [3] Diazepam-Loaded Solid Lipid Nanoparticles: Design and Characterization
    Abdelbary, Ghada
    Fahmy, Rania H.
    [J]. AAPS PHARMSCITECH, 2009, 10 (01): : 211 - 219
  • [4] Optimization and In vivo Pharmacokinetic Study of a Novel Controlled Release Venlafaxine Hydrochloride Three-Layer Tablet
    Aboelwafa, Ahmed A.
    Basalious, Emad B.
    [J]. AAPS PHARMSCITECH, 2010, 11 (03): : 1026 - 1037
  • [5] Hot-melt coating: Water sorption behavior of excipient films
    Achanta, AS
    Adusumilli, PS
    James, KW
    Rhodes, CT
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2001, 27 (03) : 241 - 250
  • [6] Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting
    Alex, M. R. Aji
    Chacko, A. J.
    Jose, S.
    Souto, E. B.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 42 (1-2) : 11 - 18
  • [7] [Anonymous], 2004, Int J Toxicol, V23 Suppl 2, P55
  • [8] [Anonymous], DRUG DEV IND PHARM
  • [9] [Anonymous], UNITED STATES PHARMA
  • [10] [Anonymous], GUIDANCE FOR INDUSTR